Evoke Pharma, Inc. - Common Shares (EVOK)

Historical Holders from Q2 2022 to Q3 2024

Symbol
EVOK on Nasdaq
CUSIP
30049G203
Type / Class
Equity / Common Shares
Shares outstanding
1.58M
All holders as of September 30, 2024
Q3 2024
Shares, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-14
Average Value change %
0%
Average sells %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Evoke Pharma, Inc. - Common Shares (EVOK)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nantahala Capital Management, LLC 15.99% $102K 255K Nantahala Capital Management, LLC Feb 3, 2025
Bleichroeder LP 9.99% 0% $63.2K 158K -81.4% Bleichroeder LP Mar 24, 2025

Institutional Holders of Evoke Pharma, Inc. - Common Shares (EVOK)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 0 $0 -$1.67M 0
2024 Q2 3.15M $1.67M -$8.06K $0.53 15
2024 Q1 3.16M $1.93M +$1.89M $0.61 14
2023 Q4 68.4K $71.8K +$862 $1.05 8
2023 Q3 67.2K $92.4K +$11K $1.38 8
2023 Q2 59.2K $97.4K -$18.7K $1.65 8
2023 Q1 68.9K $131K +$15.4K $1.90 10
2022 Q4 60.6K $161K -$3.4K $2.68 9
2022 Q3 62.1K $116K -$14.9K $1.87 5
2022 Q2 69.4K $226K +$226K $3.29 6